Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Loupy

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2017
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft RecipientsJ Choi, O Aubert, A Vo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2018
Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donorsA H Querard, F Le Borgne, A Dion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donorsD Anglicheau, A Loupy, C Lefaucheur, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot studyD Anglicheau, A Loupy, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2009
Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantationR Snanoudj, M Rabant, M O Timsit, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 21, 2015
Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated RejectionA Loupy, C Toquet, P Rouvier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 5, 2011
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)A Loupy, G S Hill, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathyA Loupy, A Cazes, R Guillemain, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2017
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft RecipientsJ Choi, O Aubert, A Vo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2018
Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donorsA H Querard, F Le Borgne, A Dion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donorsD Anglicheau, A Loupy, C Lefaucheur, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot studyD Anglicheau, A Loupy, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2009
Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantationR Snanoudj, M Rabant, M O Timsit, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 21, 2015
Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated RejectionA Loupy, C Toquet, P Rouvier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 5, 2011
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)A Loupy, G S Hill, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathyA Loupy, A Cazes, R Guillemain, et al.
Pageof 3